Therapy News and Research

RSS

NIH study helps explain survival rate discrepancy between cardiac arrest in public and home

Cardiac arrests that can be treated by electric stimulation, also known as shockable arrests, were found at a higher frequency in public settings than in the home, according to a National Institutes of Health-funded study appearing in the Jan. 27 issue of the New England Journal of Medicine.

27 Jan 2011

Pfenex receives $3.1 million SAIC sub-contract to develop malaria antigen

Pfenex today announced that Science Applications International Corporation has awarded Pfenex a sub-contract valued at $3.1 million to help develop a robust, scalable, cGMP ready production process for large scale production of full length Circumsporozoite protein from Plasmodium falciparum.

27 Jan 2011

Researchers discover new sensory neurons that mediate BP and metabolism regulation in liver

For 60 years, scientists have puzzled over the possibility of a hepatic osmoreceptor that influences blood pressure regulation. Now, researchers of the Max Delbr-ck Center for Molecular Medicine Berlin-Buch, the Experimental and Clinical Research Center of the MDC and Charit- and the Hannover Medical School appear to have made a breakthrough discovery.

27 Jan 2011

Lancet series examines health issues facing populations in Southeast Asia

"Southeast Asia's 600 million people are facing a raft of new health challenges as the disaster-prone region undergoes some of the world's fastest social change," according to a series of papers and commentary pieces, published Tuesday in the Lancet, Agence France-Presse reports (O'Brien, 1/25).

27 Jan 2011

Targeting UROD enzyme boosts effects of radiotherapy and chemotherapy in head, neck tumors

Cancer researchers at Princess Margaret Hospital (PMH) have discovered that targeting an enzyme called Uroporphyrinogen Decarboxylase (UROD) can sensitize diseased tissue to radiation and chemotherapy, which could mean fewer side effects for individuals with head and neck cancer.

27 Jan 2011

MGH investigators develop novel system to deliver growth factors to chronic wounds

Massachusetts General Hospital investigators have developed a novel system for delivery of growth factors to chronic wounds such as pressure sores and diabetic foot ulcers.

27 Jan 2011

Tryton initiates enrollment in Side Branch Stent System study

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first U.S. patient has been enrolled in the pivotal trial to evaluate the Tryton Side Branch Stent System™ for the treatment of coronary artery disease.

27 Jan 2011

Elimination of glucagon action may help convert Type 1 diabetes into non-insulin-dependent disorder

Type 1 diabetes could be converted to an asymptomatic, non-insulin-dependent disorder by eliminating the actions of a specific hormone, new findings by UT Southwestern Medical Center researchers suggest.

27 Jan 2011

Potential therapy to enhance memory and prevent loss of long-term memory

Researchers from Mount Sinai School of Medicine have identified a therapy that may enhance memory and prevent the loss of long-term memory. The research is published in the January 27th issue of Nature.

27 Jan 2011

Feeding regimens may improve respiratory health in premature babies with lung disease

Improving lung function in premature babies with a severe lung disease may be linked to their feeding regimen, according to a new University of Michigan study.

27 Jan 2011

Nexstim closes additional equity financing for approximately EUR 11.4 million

Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, today announced that it has closed on additional equity financing of approximately EUR 11.4 million.

27 Jan 2011

Study: Low SES is linked to high risk of depression in patients with RA

Physical and Mental Health Disparities Found in Those with Low Socioeconomic Position. A recent study confirmed that low socioeconomic status is associated with higher risk of depressive symptoms in patients with rheumatoid arthritis.

26 Jan 2011

Anadys begins dosing in ANA598 Phase IIb study for hepatitis C

Anadys Pharmaceuticals, announced today that dosing has begun in the Phase IIb study of ANA598 in combination with pegylated interferon and ribavirin in hepatitis C patients.

26 Jan 2011

Researchers develop anti-HIV gene therapy for rendering T-cells resistant to infection

An innovative genetic strategy for rendering T-cells resistant to HIV infection without affecting their normal growth and activity is described in a paper published in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. The paper is available free online.

26 Jan 2011

ASTRO reaffirms commitment to quality, issues progress report on patient safety plan

The American Society for Radiation Oncology is continuing its commitment to Target Safely, a six-point patient protection plan developed in January 2010, to improve the safety and quality of radiation therapy treatments and reduce the chances of medical errors.

26 Jan 2011

Mental health laws delayed to take into account public opinion

The Victorian government has extended the closing date for public comment on changes to the state’s Mental Health Act. The deadline has been extended to February 28. Submissions on the Exposure Draft Mental Health Bill 2010 can be lodged online.

26 Jan 2011

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

RNL BIO CO., LTD, a leading biopharmaceutical company specialized in adult stem cell therapeutics, announced on January 21, 2011 another successful patient report utilizing stem cell therapy on a leading US orthopedic spine surgeon who suffered from Autoimmune Arthritis.

26 Jan 2011

Survival following transplant surgery for liver cancer not impacted by HIV-positive status

French researchers determined that infection with human immunodeficiency virus (HIV) impaired results of transplant surgery for liver cancer, with more HIV infected patients dropping off the transplantation wait list. The team found that overall survival and recurrence-free survival was not impacted following liver transplantation in patients with controlled HIV disease.

25 Jan 2011

Evaluating patients for genetic variations impacts adherence to antiviral therapy

In two recent studies, researchers have identified two functional variants in the inosine triphosphatase (ITPA) gene that protect patients with hepatitis C virus (HCV) against anemia brought on by antiviral treatment. The ability to identify those patients protected against treatment-induced anemia will ensure completion of antiviral therapy and successful elimination of the virus.

25 Jan 2011

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.

25 Jan 2011

Therapy News and Research

NIH study helps explain survival rate discrepancy between cardiac arrest in public and home

Pfenex receives $3.1 million SAIC sub-contract to develop malaria antigen

Researchers discover new sensory neurons that mediate BP and metabolism regulation in liver

Lancet series examines health issues facing populations in Southeast Asia

Targeting UROD enzyme boosts effects of radiotherapy and chemotherapy in head, neck tumors

MGH investigators develop novel system to deliver growth factors to chronic wounds

Tryton initiates enrollment in Side Branch Stent System study

Elimination of glucagon action may help convert Type 1 diabetes into non-insulin-dependent disorder

Potential therapy to enhance memory and prevent loss of long-term memory

Feeding regimens may improve respiratory health in premature babies with lung disease

Nexstim closes additional equity financing for approximately EUR 11.4 million

Study: Low SES is linked to high risk of depression in patients with RA

Anadys begins dosing in ANA598 Phase IIb study for hepatitis C

Researchers develop anti-HIV gene therapy for rendering T-cells resistant to infection

ASTRO reaffirms commitment to quality, issues progress report on patient safety plan

Mental health laws delayed to take into account public opinion

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

Survival following transplant surgery for liver cancer not impacted by HIV-positive status

Evaluating patients for genetic variations impacts adherence to antiviral therapy

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News